T1	disease_or_phenotypic_feature 19 25	anemia
T2	chemical 34 40	oxygen
T3	chemical 55 62	polymer
T4	disease_or_phenotypic_feature 107 121	gastric cancer
T5	disease_or_phenotypic_feature 152 159	obesity
T6	disease_or_phenotypic_feature 161 169	arterial
T7	chemical 184 192	nicotine
T8	chemical 197 204	alcohol
T9	chemical 255 265	fluoxetine
T10	disease_or_phenotypic_feature 310 316	autism
T11	disease_or_phenotypic_feature 359 366	obesity
T12	chemical 371 375	food
T13	chemical 430 453	calcium-channel blocker
T14	chemical 454 463	verapamil
T15	disease_or_phenotypic_feature 498 516	hyperprolactinemia
T16	disease_or_phenotypic_feature 566 577	Thalassemia
T17	chemical 595 599	iron
T18	disease_or_phenotypic_feature 610 625	cardiac failure
T19	disease_or_phenotypic_feature 627 644	diabetes mellitus
T20	disease_or_phenotypic_feature 646 661	hypopituitarism
T21	chemical 761 771	inhibitors
T22	chemical 775 783	tyrosine
T23	disease_or_phenotypic_feature 825 831	glioma
T24	chemical 833 843	inhibitors
T25	chemical 879 882	ras
T26	chemical 924 927	ras
T27	disease_or_phenotypic_feature 934 939	NSCLC
T28	chemical 1009 1017	nitrogen
T29	chemical 1082 1091	yohimbine
T30	chemical 1114 1118	drug
T31	disease_or_phenotypic_feature 1123 1130	obesity
T32	chemical 1146 1152	oxygen
T33	disease_or_phenotypic_feature 1229 1244	cervical cancer
T34	chemical 1275 1286	aldosterone
T35	disease_or_phenotypic_feature 1297 1301	COPD
T36	disease_or_phenotypic_feature 1316 1321	edema
T37	disease_or_phenotypic_feature 1369 1374	edema
T38	chemical 1379 1385	sodium
T39	chemical 1390 1395	water
T40	disease_or_phenotypic_feature 1443 1447	COPD
T41	chemical 1489 1500	vasopressin
T42	chemical 1508 1527	receptor antagonist
T43	chemical 1528 1537	tolvaptan
T44	disease_or_phenotypic_feature 1603 1615	hypertensive
T45	disease_or_phenotypic_feature 1616 1629	heart failure
T46	chemical 1666 1673	18F-FDG
T47	chemical 1708 1715	18F-FDG
T48	chemical 1731 1736	probe
T49	disease_or_phenotypic_feature 1818 1831	breast cancer
T50	disease_or_phenotypic_feature 1839 1845	cancer
T51	chemical 1882 1889	antigen
T52	chemical 1937 1944	antigen
T53	chemical 1990 2002	Levosimendan
T54	chemical 2008 2015	calcium
T55	chemical 2028 2032	drug
T56	disease_or_phenotypic_feature 2054 2067	heart failure
T57	disease_or_phenotypic_feature 2146 2152	median
T58	chemical 2159 2165	oxygen
T59	chemical 2214 2221	agonist
T60	chemical 2223 2233	retigabine
T61	chemical 2239 2248	cisplatin
T62	disease_or_phenotypic_feature 2257 2278	peripheral neuropathy
T63	chemical 2280 2289	Buckwheat
T64	chemical 2290 2297	trypsin
T65	chemical 2298 2307	inhibitor
T66	disease_or_phenotypic_feature 2404 2411	obesity
T67	disease_or_phenotypic_feature 2413 2426	hyperglycemia
T68	disease_or_phenotypic_feature 2431 2445	hyperlipidemia
T69	chemical 2468 2475	antigen
T70	disease_or_phenotypic_feature 2485 2491	cancer
T71	chemical 2549 2557	antigens
T72	corrected_disease_or_phenotypic_feature 13 25	renal anemia
T74	corrected_disease_or_phenotypic_feature 161 182	arterial hypertension
T75	missed_disease_or_phenotypic_feature 666 679	porphyrinuria
T76	missed_chemical 964 969	BCAAs
T77	missed_chemical 998 1003	BCAAs
T78	missed_chemical 1061 1065	BCAA
T79	missed_chemical 1096 1113	alpha-adrenolytic
R2	treats Arg1:T43 Arg2:T44	
R3	treats Arg1:T43 Arg2:T45	
R4	treats Arg1:T53 Arg2:T56	
T80	corrected_chemical 2202 2221	Kv7 channel agonist
R5	treats Arg1:T80 Arg2:T62	
T81	missed_disease_or_phenotypic_feature 2239 2278	cisplatin-induced peripheral neuropathy
T82	corrected_chemical 2280 2307	Buckwheat trypsin inhibitor
T83	missed_chemical 2309 2312	BTI
R6	treats Arg1:T82 Arg2:T66	
R7	treats Arg1:T82 Arg2:T67	
R8	treats Arg1:T82 Arg2:T68	
T84	DONE 2559 2563	DONE
R9	treats Arg1:T9 Arg2:T10	
R10	causes_or_contributes_to Arg1:T12 Arg2:T11	
R11	treats Arg1:T29 Arg2:T31	
T85	corrected_disease_or_phenotypic_feature 1603 1629	hypertensive heart failure
R13	causes_or_contributes_to Arg1:T61 Arg2:T62	
T87	missed_disease_or_phenotypic_feature 2377 2395	metabolic diseases
R14	treats Arg1:T82 Arg2:T87	
R15	treats Arg1:T83 Arg2:T87	
R16	treats Arg1:T83 Arg2:T68	
R17	treats Arg1:T83 Arg2:T66	
R18	treats Arg1:T83 Arg2:T67	
T73	corrected_chemical 1096 1118	alpha-adrenolytic drug
R1	treats Arg1:T73 Arg2:T31	
T86	corrected_chemical 1489 1527	vasopressin type 2 receptor antagonist
R12	treats Arg1:T86 Arg2:T85	
T88	corrected_chemical 2008 2032	calcium-sensitizing drug
R19	treats Arg1:T88 Arg2:T56	
